CSBR:NASDAQ
Champions Oncology Inc
$4.75
arrow_downward
-1.86%(-0.090) 1D
Nov 10, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.82
High
$4.88
Low
$4.75
Mkt. cap
66.11M
Avg. vol.
9.19K
Volume
8.60K
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.82
High
$4.88
Low
$4.75
Mkt. cap
66.11M
Avg. vol.
9.19K
Volume
8.60K
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
Benzinga
·
36 minutes ago
Dow Falls Over 150 Points Following Inflation Report: Greed Index Remains In ‘Fear’ Zone
Yahoo Finance
·
1 hour ago
Dow, S&P 500, Nasdaq Futures Edge Higher After Red-Hot Inflation Data And Nvidia Losses: CRWV, TTWO, NLST, NBIS In Focus
Big News Network.com
·
7 hours ago
Dow Jones slides 158 points Tuesday, Nasdaq sheds 187
Traders Union
·
3 hours ago
Correlations rose sharply between ex-AI basket and S&P 500 last week, Jurrien Timmer notes
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com